Sophie Bai

Founder & CEO, B.A.I. Biosciences

Prior to founding B.A.I. Biosciences, Inc., Sophie was a healthcare and life sciences investor at Bain Capital Private Equity, and a management consultant at Boston Consulting Group.

Sophie developed a passion for science at a young age. She discovered an anti-aging compound at the age of 16 and a minor planet (Planet No.25045) was named after her by NASA and MIT Lincoln Laboratory to recognize her scientific accomplishment. She studied Chemical Engineering with a focus on Biomedical Engineering at MIT, where she worked with Institute Professor Robert Langer developing various drug delivery technologies to find cures for prostate cancer, lung cancer, and type I diabetes. Sophie has invented, co-invented, and patented multiple proprietary molecules to provide cures and treatment for Atopic Dermatitis (eczema), skin cancer, and skin aging.

Sophie is a serial entrepreneur. She founded PPEople First, a venture philanthropy vehicle that procured 2 million pieces of N95 respirators, surgical masks, medical gowns, face shields, and gloves to donate to 27 hospitals and senior care facilities in Massachusetts during the peak of COVID-19 in 2020 when the need for PPE was dire.

Prior to founding B.A.I. Biosciences, Inc., Sophie was a healthcare and life sciences investor at Bain Capital Private Equity, and a management consultant at Boston Consulting Group advising pharmaceutical and beauty companies. Sophie received her Bachelor of Science in Chemical Engineering from Massachusetts Institute of Technology and her Master of Business Administration from Harvard Business School. She was elected as the Blavatnik Fellow in Life Sciences Entrepreneurship at Harvard University shortly after founding B.A.I.. Sophie is a member of American Academy of Dermatology.